Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A microglial hypothesis of globoid cell leukodystrophy pathology.
Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis.
Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust.
Treatment with NAD(+) inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice.
Structural sex differences at disease onset in multiple sclerosis patients.
Pediatric multiple sclerosis: Perspectives from adolescents and their families.
Therapeutic antibodies for spinal cord injury.
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.
Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.
DNA Methylation: a New Player in Multiple Sclerosis.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
[Improving the sexual quality of life of people with multiple sclerosis].
High-resolution three-dimensional macromolecular proton fraction mapping for quantitative neuroanatomical imaging of the rodent brain in ultra-high magnetic fields.
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis.

Pages